Aratana Therapeutic (PETX) Reports Q2 Loss of $4.62
Tweet Send to a Friend
Aratana Therapeutic (NASDAQ: PETX) reported Q2 EPS of ($4.62), $5.59 better than last year ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
